Fatal aplastic anemia resulting from flucytosine.
D000284:Administration, Oral; D000741:Anemia, Aplastic / Q000139:chemically induced*; D000935:Antifungal Agents / Q000009:adverse effects*; D003453:Cryptococcosis / Q000188:drug therapy; D003455:Cryptococcus neoformans / Q000302:isolation & purification; D003596:Cytosine / Q000009:adverse effects*; D005437:Flucytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008581:Meningitis / Q000188:drug therapy
D000935:Antifungal Agents; D003596:Cytosine; D005437:Flucytosine